One option: nasal vaccines, which would be sprayed into our noses — no needles required. Beyond sidestepping people’s fear of needles, these vaccines would also make it easier to store and ...

No hospitals, no needles, no pain, only gain. “This provides a new option for receiving a safe and effective seasonal influenza vaccine potentially with greater convenience, flexibility and ...

SUITA, Osaka Prefecture--A researcher holds up a blue plastic medical device, resembling a crafting glue gun, which could one day replace needles as the main delivery method for vaccines.

On a basic level, companies able to offer an alternative form of vaccine delivery to traditional options can set themselves apart from competitors. Needle phobia is a well-known problem ...

To compare EI with needle injection through these conventional routes, we used a formalin-inactivated Aichi/68 influenza virus to immunize BALB/c mice (n = 8 per group). For EI, the vaccine was ...

Vaxxas, a clinical-stage biotechnology company, today announced it has secured a new patent from the United States patent office covering proprietary manufacturing technology for its novel vaccination ...

lined with microscopic needles, onto their skin. “It’s an excellent, extremely comprehensive and well-done study,” said Mark Poznansky, director of the Vaccine and Immunotherapy Centre at ...

For example, certain vaccines can be delivered orally, as a drop on the tongue, or via a jet-like device. Scientists are developing COVID-19 vaccine which can be administered without needles.… SBS ...

Vaxxas’ proprietary high-density microarray patch (HD-MAP) technology is currently being evaluated in a phase 1 clinical study of the first needle-free COVID-19 vaccine, having demonstrated ...

Over the past five years, researchers at Emory University and the Georgia Institute of Technology have developed a dime-sized vaccine patch sprinkled with a hundred microscopic needles and coated with ...

Transcutaneous immunization, a topical vaccine application, combines the advantages of needle-free delivery while ... A graded-dose phase I trial was conducted in 18 volunteers to evaluate the ...

The eyes may be windows to the soul, but the nose is a gateway to the mucosal immune system. Drug companies are now developing vaccines to take advantage of that gateway. Courtesy of Aviron MISTING UP ...